The push to abandon animal testing is gaining momentum, driven by the realization that it is costly, unreliable and ...
China's biotech revival is pushing up prices of laboratory monkeys used in drug testing, as renewed R&D activity collides ...
Bioprinting is rapidly moving from research labs into commercial reality, and it is reshaping how the pharmaceutical and ...
A new study found that fixing energy balance in the brain reversed symptoms of advanced Alzheimer’s in mice. Researchers ...
First-ever fentanyl overdose prevention vaccine could save thousands of lives annually, with human trials beginning early ...
The new tests for autism are not yet reliable enough to be offered commercially. None of the tests has gone through large ...
The World Health Organization (WHO) has published its new 2025 Guidelines on the replacement or removal of animal tests for the quality control of biological products.
One county in Ohio has seen an increase in a drug that is intended for animal use. It’s called xylazine, and veterinarians ...
The cost of the monkeys — a proxy for the volume of clinical trials — is projected to reach Rmb150,000 ($21,000) at the start ...
Distinguished drug-development and biomarker leader to advance NAMkind™ scientific strategy, translational insights, and next-generation toxicology platforms ...
Chicago hospitals and health companies head into 2026 facing reimbursement pressure, rising premiums, uninsured worries and ...
In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results